GAITHERSBURG, Md. (PRWEB) April 24, 2018
Dr. Bednárik is leading the Molecular Engineering & Protein Design Dept. for NexImmune - He has over 30 years experience as a translational scientist and executive specializing in moving promising technologies into product development. He was previously Vice President, Molecular Engineering Unit at Intrexon Corp. where he led a team of scientists developing innovative methods for cellular therapies for cancer. Prior to that, Dr. Bednárik held senior positions at Cardiome Pharma Corporation, Artesian Therapeutics, Inc., and Gene Logic, Inc. and led various projects focused on translational medicine spanning several therapeutic areas including cancer and cardiovascular diseases. Among other accomplishments he created the largest known cardiovascular transcriptomic gene expression database for Gene Logic, Inc. He was also the recipient of a $1.7M DARPA contract in 2006 for the development of a novel non-host method for rapid vaccine manufacture. Earlier in his career, Dr. Bednárik served as a Senior Scientist for Human Genome Sciences (HGS) and completed a post-doctoral fellowship at The Johns Hopkins University Oncology Center.